Literature DB >> 9921863

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies.

D S Molenaar1, M Vermeulen, M de Visser, R de Haan.   

Abstract

OBJECTIVE: To determine whether the Neurologic Disability Score (NDS), the Neuropathic Symptom Score (NSS), and the Medical Research Council (MRC) "sumscore" are reliable, and to determine whether they provide information regarding the functional status of patients with peripheral neuropathies.
METHODS: The authors analyzed homogeneity of the frequently used outcome measures in 97 patients using Cronbach's alpha coefficient and corrected item-total correlations. Their association with functional status (sickness impact profile and modified Rankin score) was analyzed univariately with Pearson's and Spearman's correlation coefficients, and multivariately with linear regression analysis.
RESULTS: The NDS and MRC scales were homogeneous (range of Cronbach's alpha, 0.81 to 0.97) compared with the NSS scales (range, 0.20 to 0.63). The correlation patterns between neurologic signs and symptoms and functional status ranged from 0.13 to 0.65. Multivariate linear regression analyses showed that 40% or less of patients' functional status could be explained by the three tested outcome measures.
CONCLUSION: The NDS and MRC are reliable measures, but these measures do not correlate with measures of functional status.

Entities:  

Mesh:

Year:  1999        PMID: 9921863     DOI: 10.1212/wnl.52.1.151

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Connecting impairment, disability, and handicap in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

Review 3.  Immunoglobulin for multifocal motor neuropathy.

Authors:  Stephen Keddie; Filip Eftimov; Leonard H van den Berg; Ruth Brassington; Rob J de Haan; Ivo N van Schaik
Journal:  Cochrane Database Syst Rev       Date:  2022-01-11

4.  Fatigue is part of the burden of neuromuscular diseases.

Authors:  John H J Wokke
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

Review 5.  Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.

Authors:  Justin Cohen; Alec DeSimone; Monkol Lek; Angela Lek
Journal:  Trends Mol Med       Date:  2020-10-19       Impact factor: 11.951

6.  The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).

Authors:  Karlien Mul; Tatiana Hamadeh; Corinne G C Horlings; Rabi Tawil; Jeffrey M Statland; Sabrina Sacconi; Alastair J Corbett; Nicol C Voermans; Catharina G Faber; Baziel G M van Engelen; Ingemar S J Merkies
Journal:  Eur J Neurol       Date:  2021-05-02       Impact factor: 6.089

Review 7.  The impact of disease-related impairments on disability and health-related quality of life: a systematic review.

Authors:  Nadine Weisscher; Rob J de Haan; Marinus Vermeulen
Journal:  BMC Med Res Methodol       Date:  2007-06-19       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.